BE894185A - Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain - Google Patents

Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain

Info

Publication number
BE894185A
BE894185A BE6/47701A BE6047701A BE894185A BE 894185 A BE894185 A BE 894185A BE 6/47701 A BE6/47701 A BE 6/47701A BE 6047701 A BE6047701 A BE 6047701A BE 894185 A BE894185 A BE 894185A
Authority
BE
Belgium
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Application number
BE6/47701A
Other languages
English (en)
French (fr)
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE894185A publication Critical patent/BE894185A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE6/47701A 1981-08-27 1982-08-24 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain BE894185A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
BE894185A true BE894185A (fr) 1983-02-24

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47701A BE894185A (fr) 1981-08-27 1982-08-24 Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain

Country Status (20)

Country Link
JP (1) JPS5846024A (cs)
AU (1) AU551879B2 (cs)
BE (1) BE894185A (cs)
CA (1) CA1176158A (cs)
CH (1) CH650679A5 (cs)
DE (1) DE3232034A1 (cs)
DZ (1) DZ452A1 (cs)
FR (1) FR2513126B1 (cs)
GB (1) GB2104382B (cs)
IE (1) IE54119B1 (cs)
IL (1) IL66611A0 (cs)
IT (1) IT1153182B (cs)
LU (1) LU84359A1 (cs)
MW (1) MW3882A1 (cs)
NL (1) NL192192C (cs)
NZ (1) NZ201682A (cs)
PH (1) PH19361A (cs)
SE (1) SE460334B (cs)
ZA (1) ZA826159B (cs)
ZW (1) ZW17482A1 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
NZ223630A (en) * 1987-02-25 1989-11-28 Novo Industri As Insulin derivative and pharmaceutical compositions
DE3863027D1 (de) * 1987-08-14 1991-07-04 Akzo Nv Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes.
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
JP4874989B2 (ja) 2004-11-22 2012-02-15 ノヴォ ノルディスク アー/エス 可溶性で安定なインスリン含有調合物
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
CN103119055A (zh) * 2010-05-17 2013-05-22 塞比克斯公司 聚乙二醇化c肽
US8962553B2 (en) 2011-11-17 2015-02-24 Cebix Ab Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
GB2104382B (en) 1984-12-19
CA1176158A (en) 1984-10-16
CH650679A5 (de) 1985-08-15
JPS5846024A (ja) 1983-03-17
PH19361A (en) 1986-04-02
NL8203315A (nl) 1983-03-16
AU551879B2 (en) 1986-05-15
ZA826159B (en) 1984-04-25
IT1153182B (it) 1987-01-14
DE3232034C2 (cs) 1991-04-11
IT8223017A1 (it) 1984-02-27
FR2513126A1 (fr) 1983-03-25
SE8204873L (sv) 1983-02-28
MW3882A1 (en) 1984-07-11
SE8204873D0 (sv) 1982-08-25
NL192192B (nl) 1996-11-01
DZ452A1 (fr) 2004-09-13
GB2104382A (en) 1983-03-09
NZ201682A (en) 1985-08-16
IE54119B1 (en) 1989-06-21
IE822064L (en) 1983-02-27
SE460334B (sv) 1989-10-02
LU84359A1 (fr) 1983-02-28
ZW17482A1 (en) 1982-11-17
IT8223017A0 (it) 1982-08-27
IL66611A0 (en) 1982-12-31
AU8759482A (en) 1983-03-03
DE3232034A1 (de) 1983-03-10
FR2513126B1 (fr) 1986-04-18
NL192192C (nl) 1997-03-04

Similar Documents

Publication Publication Date Title
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
BR8203384A (pt) Sistema para tratamento do sangue de um paciente
FR2513126B1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain
BE894188A (fr) Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaine
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
BE894187A (fr) Formulations pharmaceutiques comprenant de l'insuline humaine un c- peptide humain et de la pro-insuline humaine
FR2511866B1 (fr) Formulations pharmaceutiques de pro-insuline humaine
IT1165553B (it) Composizione farmaceutica con attivita' antiaterosclerotica e procedimento per la sua preparazione
IT8420759A1 (it) Composizione ad attivita' farmaceutica perfezionata e sua utilizzazione per usi veterinari
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
BE885510A (fr) Medicament omni-potent dans la therapeutique contre la sclerose en plaque et l'arterio-sclerose
IT8105040U1 (it) Apparecchio erogatore d'ossigeno a scopi terapeutici e sanitari.
JO1236B1 (en) Pharmacy formulations that include human insulin and a human-c-peptide
RO82340A2 (ro) Unguent utilizabil in terapia tulburarilor cardiace
IT8423620A0 (it) Apparecchio per il trattamento di pellicole radiografiche per uso dentario e procedimento per ottenere un'immagine radiografica dentaria.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 20020824